Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Piazza

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
Leukemia|March 6, 2026
RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphomaSilvia Lonardi, Valeria Cancila, Gaia Morello, et al.
American Journal of Hematology|December 14, 2021
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL studyAndrea Visentin, Francesca Romana Mauro, Francesca Cibien, et al.
American Journal of Hematology|April 10, 2026
A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell LymphomaGabriele Gugliotta, Lisa Argnani, Martina Cantelli, et al.
Journal of Clinical Medicine|January 11, 2025
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian StudySimone Zoletto, Marco Pizzi, Andrea De Crescenzo, et al.
American Journal of Hematology|August 12, 2020
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapiesMarzia Varettoni, Angela Ferrari, Anna M Frustaci, et al.
Hemasphere|November 29, 2023
CK2β Regulates Hematopoietic Stem Cell Biology and ErythropoiesisLaura Quotti Tubi, Sara Canovas Nunes, Elisa Mandato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana LinfomiMichele Merli, Sara Rattotti, Michele Spina, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2026
B-cell and plasma cell proliferations associated with T follicular helper cell lymphomas: clinical-pathological and genetic featuresMarco Pizzi, Luisa Lorenzi, Andrea De Crescenzo, et al.
Frontiers in Immunology|January 30, 2023
CK2β-regulated signaling controls B cell differentiation and functionLaura Quotti Tubi, Elisa Mandato, Sara Canovas Nunes, et al.
Blood Advances|February 12, 2026
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström Macroglobulinaemia? A real-life multicentre Italian studyFrancesco Autore, Alessandra Tedeschi, Giulia Benevolo, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Leukemia|March 6, 2026
RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphomaSilvia Lonardi, Valeria Cancila, Gaia Morello, et al.
American Journal of Hematology|December 14, 2021
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL studyAndrea Visentin, Francesca Romana Mauro, Francesca Cibien, et al.
American Journal of Hematology|April 10, 2026
A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell LymphomaGabriele Gugliotta, Lisa Argnani, Martina Cantelli, et al.
Journal of Clinical Medicine|January 11, 2025
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian StudySimone Zoletto, Marco Pizzi, Andrea De Crescenzo, et al.
American Journal of Hematology|August 12, 2020
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapiesMarzia Varettoni, Angela Ferrari, Anna M Frustaci, et al.
Hemasphere|November 29, 2023
CK2β Regulates Hematopoietic Stem Cell Biology and ErythropoiesisLaura Quotti Tubi, Sara Canovas Nunes, Elisa Mandato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana LinfomiMichele Merli, Sara Rattotti, Michele Spina, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2026
B-cell and plasma cell proliferations associated with T follicular helper cell lymphomas: clinical-pathological and genetic featuresMarco Pizzi, Luisa Lorenzi, Andrea De Crescenzo, et al.
Frontiers in Immunology|January 30, 2023
CK2β-regulated signaling controls B cell differentiation and functionLaura Quotti Tubi, Elisa Mandato, Sara Canovas Nunes, et al.
Blood Advances|February 12, 2026
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström Macroglobulinaemia? A real-life multicentre Italian studyFrancesco Autore, Alessandra Tedeschi, Giulia Benevolo, et al.
Pageof 21